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the second group in public sector was cephalosporins (4%) and in private sector were 
penicillins (3%). In private sector pediatricians prescribed antibiotics to 52% (17/33) 
of children with diarrhea and ﬂ uoroquinolone group was prescribed to all. At public 
facilities, main members from ﬂ uoroquinolones were norﬂ oxacin, followed by oﬂ oxa-
cin and ciproﬂ oxacin. At private clinics, it was oﬂ oxacin followed by ciproﬂ oxacin. 
Pediatricians mainly prescribed oﬂ oxacin, followed by norﬂ oxacin. CONCLUSIONS: 
This study clearly shows over-prescription and irrational use of antibiotics for treat-
ment of diarrhea that warrants interventional strategies. 
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OBJECTIVES: To analyze the pattern of non-prescription medicine purchase by 
consumer from community pharmacies in Malaysia. METHODS: A cross-sectional 
survey comprised a sample of 1799 community pharmacy consumers was conducted 
nationwide. A pharmacy “exit survey” was developed and administered to pharmacy 
consumers of randomly selected community pharmacies in order to collect information 
on the purchased nonprescription medicine(s) including its costs. In this study, the 
nonprescription medicine deﬁ nition was adopted from the Malaysian Poison Act 
1952. Data were analyzed using Kruskal–Wallis, Mann–Whitney, chi-square and 
Spearman correlation test in SPSS v15. RESULTS: A total of 2175 nonprescription 
medicines were purchased by consumers interviewed in 2 weeks study period. The 
total cost estimated for all item purchased was RM41,000 (USD13,000). About 
39.6% of the purchased items are listed under scheduled poison, 45.5% were unsched-
uled poison and 12.5% are those listed as traditional and complementary medicine. 
Medicine for alimentary tract and metabolism, musculo-skeletal system and respira-
tory system as categorized by Anatomical Therapeutic Coding were among the highest 
purchased medicine. Factors such as gender especially females, area of origin especially 
those from urban area, ethnicity especially chinese consumers and those earning high 
income level shows to have a signiﬁ cant inﬂ uence in the spending for non-prescription 
medicine purchasing. This study also showed purchasing for non-prescription medi-
cine signiﬁ cantly increased as aging. Consumers spent signiﬁ cantly more on non-
controlled medicine such as vitamins and herbal preparations compared to other 
categories of medicines (χ2 = 185.07, P < 0.001). CONCLUSIONS: The evaluation 
on pattern of nonprescription medicine purchasing in Malaysia reveals that consumers 
in Malaysia are able to spend money for buying medicines to treat minor ailments 
and practice of self-medication. The socio-demographic factors that associated with 
non-prescription medicine purchase will serve as useful information for policymakers 
and also the pharmaceutical industry for future development in rational medicine use 
education among consumers in the country. 
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OBJECTIVES: Public awareness of rare diseases and access to orphan drugs is increas-
ing in China. The purpose of this study was to review the epidemics of rare diseases, 
the access to orphan drug treatments, and its related legislation in China. METHODS: 
A systematic literature review was performed based on published articles, government 
Websites, and some Internet search engines. The rare diseases, available orphan drug 
treatments, and related legislations in China were reviewed. Some comparisons related 
to these topics were discussed between China and developed countries like the United 
States. RESULTS: With conservative estimation, there are at least 10 million Chinese 
people living with rare diseases. The frequently mentioned rare diseases in China 
include osteogenesis imperfecta, neuromuscular diseases, Fabry disease, Gaucher 
disease, phenylketonurias, hemophilia A and B, lymphangioleiomyomatosis, albinism, 
and acromegaly. Patients with rare diseases in China generally lack the access to 
appropriate health care especially the orphan drug therapies. While we observed the 
signiﬁ cant impact of Orphan Drug Act on new drug developments and rare disease 
treatments in developed countries, there is little new orphan drug designated or devel-
oped in China. There are very few imported orphan drugs in the Chinese market. A 
grouping number of Chinese rare-disease organizations such as the China Albinism 
Association and the China-Dolls Care and Support Association are working with 
government on a new legislation about health care assesses and insurance policy for 
rare diseases. CONCLUSIONS: Public and governmental concerns about rare diseases 
have been boosted in China. Their available treatments and legislation in China are 
lagging far behind the United States, the European Union, Australia, Singapore, Japan, 
and South Korea. An effective public health insurance and public policy are needed for 
rare disease treatments and orphan drug developments. 
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OBJECTIVES: Iran had one of the highest uses of Diphenoxylate in the world in 2008. 
About 1 billion tablets of Diphenoxylate 2.5 mg have been consumed during that year. 
In the last months of 2008 the ministry of health tried some policies to reduce the 
consumption. One was rationing in production the other was doubling the price of 
10 medicines which likely were abused including Diphenoxylate. This study tries to 
show the effectiveness of these two interventions by evaluating monthly consumption 
of Diphenoxylate during recent 5 years ended to March 2010. METHODS: Data were 
gathered from the distributors and wholesalers of this medicine from whole the 
country. These data were crosschecked with importation data in the ministry of health. 
We did a time trend analysis on tabulated data. RESULTS: There are some variations 
in monthly use of Diphenoxylate but the trend shows a signiﬁ cant decrease after the 
rationing in production. In 2009 the average consumption has reached to less than 
650 millions of tablet, four Deﬁ ned Daily Dose per 1000 Inhabitants per day which 
shows 36% decrease in comparison with the previous year. In second half of 2009 
and ﬁ rst 2 months of 2010 after the second intervention, there is no signiﬁ cant change 
in the trend. CONCLUSIONS: Although the high consumption of opiates in Iran is 
a multi factorial phenomena but this study shows; the ﬁ rst intervention has been able 
to control the abuse of Diphenoxylate due to the reduction of market supply and 
decrease in Diphenoxylate’s unofﬁ cial promotion. Considerable result wasn’t seen in 
the second approach. The user price of Diphenoxylate tablet in Iran is too cheap and 
doubling the price doesn’t work at all. A signiﬁ cant tax mark-up and increasing the 
price based on label use may affect on affordability of Diphenoxylate’s abuse. 
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OBJECTIVES: In the 1980s, China launched market-oriented reforms. Public hospi-
tals were encouraged to make their own incomes with the aim of mobilizing medical 
workers and improving hospital efﬁ ciency. Less government funding resulted in deﬁ -
cits for public health institutions, which forced hospitals to generate their own revenue 
by aggressively selling drugs, especially expensive drugs. There are challenges in poor 
drug access, drug procurement, rising drug costs and ﬁ nancial risk. In March 2009, 
China ﬁ nally unveiled its health care reform plan. The Chinese government announced 
it will institute an essential medicine system within 3 years to drive down prescription 
costs and quell public complaints of limited accessibility of medicines. This study is 
to describe the strategies to build the essential medicine system at the provincial level 
in China and challenges associated with promoting it. METHODS: Key actors, their 
power, views and interactions will be assessed using appropriate qualitative methods 
as these are best suited to understanding complexity, richness of material and motiva-
tions of actors, and using a policy analysis to know the key governance issues and 
underlying relationships affecting its success or failure. RESULTS: The system includes 
a list of essential medicines that would be produced and distributed under government 
control and supervision, and it should be used at all public health facilities at grass-
roots levels from 2009. The central government will set reference prices, based on 
which, provincial governments set the purchase prices of the drugs in their jurisdiction. 
Public medical and health facilities at the grassroots levels should sell the drugs at the 
purchase prices. These generally involve the transfer for a ﬁ xed fee from the local 
MOH to the health service center/post in exchange for the removal of retail mark up, 
which couldn’t offset the proﬁ t of selling drugs. CONCLUSIONS: The provider incen-
tive is very crucial for building an essential medicine system, which is dependent upon 
the reimbursement system. 
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OBJECTIVES: The pricing system for chemical drugs is currently applied to biologics 
in China as no speciﬁ c pricing system for biologics exists yet in China. This practice 
does not fully reﬂ ect the characteristics of biologics and may potentially prevent the 
launch of biologics in China and discourage the development of biologics. The objec-
tive of this study is to explore adequate pricing mechanisms for biologics. METHODS: 
Both primary research (ﬁ eld research, expert interviews, surveys) and secondary 
research were conducted to determine the key determinants of the price of biologics 
and understand the complexity of R&D, manufacturing and distribution required for 
biologics. Statistical analyses were performed to assess the relationship of key deter-
minants and the price. Government and manufacturer behavior were modeled using 
game theory to demonstrate prerequisites of implementing ‘differential pricing’. 
RESULTS: A different pricing system is required for biologics given its unique char-
acteristics. Certain characteristics (including special clinical value, target-speciﬁ c R&D 
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efforts, complex manufacturing process and higher distribution costs) were found to 
be the key inﬂ uencing factors when determining biologics’ prices. Since these charac-
teristics vary signiﬁ cantly depending on the type of biologics, the important ratios used 
in the pricing formula like “SG&A/sales ratio,” “yield rate,” “proﬁ t rate (innovation-
based),” “distribution mark-ups,” “VAT rate” and “differentiation mark-up (quality-
based)” have to be determined on a case by case basis. Using blood products as an 
example, three differentiation factors (clinical efﬁ cacy, gold standard ﬁ nish product 
assessment and overall manufacturing process evaluation) are key to achieve differen-
tial pricing. CONCLUSIONS: “Differential pricing” should be included in the biolog-
ics pricing system. Ratios in the existing pricing formula like “yield rate,” “distribution 
mark-up,” “proﬁ t rate” and “differentiation mark-up” should be adjusted to reﬂ ect 
the differences between biologics and chemicals. Differentiating criteria should be 
carefully chosen to reﬂ ect the value of biologics thus to develop the biopharmaceutical 
industry. 
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OBJECTIVES: Our main objective was to investigate the degree of adherence of WHO 
recommended patient care indicators in health-care facilities operatin in Galle Sri 
Lanka. METHODS: A total of 422 patients attending to the Outpatient Department 
in selected Hospitals in Galle district in Southern Province. Average Dispensing Time 
(ADT), Percentage of Drugs Actually Dispensed (PDAD), Percentage of Drugs Ade-
quately Labeled (PDAL) and Patients Knowledge on Correct Dosage (PKCD) were 
compared in these selected Teaching, General and District Hospitals in Galle. 
RESULTS: ADT in DH (1.16 min) and GH (1.07 min) were high when compared to 
ADT in TH (0.81 min). PDAD was 100% in DH, 97.79% in GH and lowest in TH 
(94.64%). PDAL was highest in 22.66% in TH, 17.57% in GH and lowest in DH 
(1.57%). PKCD was 100% in GH and lowest in DH (0%) and only 50 % in TH in 
Galle District. We noted that there was a signiﬁ cant difference in ADT, PKCD and 
average number of drugs labeled in all three categories (P < 0.05). But there was no 
signiﬁ cant difference in average no of drugs prescribed and dispensed in three catego-
ries of these hospitals. We noted that dispensers spend only short dispensing time and 
there was a tendency for dispensing errors. We found that PDAL was very low in all 
Hospitals but PDAD was signiﬁ cantly high. Even though the ADT was high in DH, 
PKCD was 0% due to unorganized dispensing practices. We also noted 100% PKCD 
only in GH due to practice of well prepared correct labeling system. CONCLUSIONS: 
Therefore we suggest to implementing proper dispensing techniques by introducing 
well prepared printed drug labeling system and commencement of recorded announce-
ments to improve patient’s knowledge on drug administration. 
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OBJECTIVES: Elderly are prone to many acute and chronic age related diseases which 
needed multiple drug usage. Therefore medicine use evaluation pattern in this group 
is very important and a signiﬁ cant part of public health system policy METHODS: 
In a cross sectional household survey, 20 clusters were selected from the post ofﬁ ce 
sampling frame in Tehran. Each cluster consists of 40 households who had at least 1 
person over the 60 years old. Questionnaire of the study was completed for all of the 
members over 60 and information about their medicine consumption was gathered. 
Data was analyzed by the prescription analyzer and SPSS soft wares. RESULTS: A 
total of 1054 men and women over 60 were enrolled to the study; 49.4% were male 
and 50.6% were female; 69% of the study population used at least one medicine per 
day regularly and 7.6% used at least one medicine none daily regularly; 46.2% used 
to consume medicines as self-medication. Mean items per prescription was 3.57 for 
patients who used medicines regularly everyday. In this group of patients, 58% used 
more than two medicines per day (poly pharmacy). Cardiovascular and central 
nervous system medicines were the most frequent medicines. Aspirin 80 mg, Atenolol 
and Calcium-D were the most frequent medicines used regularly but not daily. Acet-
aminophen 325 mg and acetaminophen codeine were the most frequent self medica-
tions. CONCLUSIONS: Our study showed that mean drug use in elderly is nearly 
same the mean of total population. This group of society is very vulnerable because 
of aging processes and multiple comorbidities. They must take many different drugs 
of variable groups which have interaction with each other. For minimizing these 
effects, physicians must be very precise in taking drug history of these patients before 
the drugs prescription. 
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OBJECTIVES: To investigate and cluster the Universiti Sains Malaysia (USM) market 
in terms of the preferred OSDF and the form that seems easy in swallowing; to deter-
mine how consumers manage their choice regarding the physical characteristics like 
size, shape, color, and taste. Gender and ethnic groups were the possible factors that 
associated with public preferences of OSDF and their different physical characteristics. 
METHODS: A self-administered questionnaire were distributed in a cross-sectional 
design to 200 individuals at the main campus of Universti Sains Malaysia and 100 
individuals outside the campus. A diagram of different oral solid dosage forms 
(capsule, tablet, caplet, and soft gelatin) was provided during the answering session. 
Data from 300 individuals were presented by frequencies and percentages for categori-
cal variables and were analyzed by chi-square test. RESULTS: Capsule was the most 
preferred OSDF and the easiest form in swallowing. Males prefer OSDF to be in blue 
color while female Prefer pink. Most respondents prefer OSDF to be without taste, 
small in size, and round in shape. The preferred physical characteristics was size fol-
lowed by taste, shape, and color respectively. A signiﬁ cant difference (P < 0.05) was 
found between gender and ethnic groups toward the preferred OSDF. CONCLU-
SIONS: Based on the result of this study, public have their preferences toward a 
particular OSDF and a particular physical characteristics. Size is the most important 
physical characteristics for the public to manage their choice regarding OSDF, fol-
lowed by taste, shape, and color. 
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OBJECTIVES: To explore potential use of the asset indexes for measuring household 
living standards, and monitoring equity in the distribution of government subsidy for 
health among different socio-economic groups of Thais. METHODS: The principal 
components analysis (PCA) is used to compute the weight or “factor score” of each 
household asset in the nationally representative household socio-economic surveys 
(SES) 2000, 2004, and 2006. Households categorized into different socio-economic 
groups between using money metric measures (income & expenditure) and the asset 
indexes were compared. Differences in the distribution of government subsidy for 
health in 2006 between using household income and the asset indexes were also 
explored. RESULTS: Households in higher asset quintiles frequently owned assets 
with a high factor score and low availability in most households, while households in 
lower quintiles did not. The assets with the top-three factor scores in 2000 and 2004 
were washing machine, telephone, and refrigerator, while those in 2002 were washing 
machine, telephone, and video recorder. In all 3 years, households in the ﬁ rst asset 
quintile (the poorest) had neither air conditioner nor computer, while 48% of house-
holds in the richest quintile owned air conditioners in 2000, and increasing to 49% 
in 2002 and 61% in 2004. The correlations between household quintiles classiﬁ ed by 
the asset index and by household income/expenditure ranged from 0.47 to 0.54. The 
distribution of government subsidy on health in 2006 between using household income 
and asset indexes is similar. CONCLUSIONS: The asset index can be used as an 
alternative tool to classify socio-economic groups of Thai households and monitoring 
health equity. Revisit of questions on assets in the household surveys can improve the 
ability of the asset index to reﬂ ect household living standards. 
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OBJECTIVES: This study investigates the public opinion on the issues of distributive 
justice in health care. From the literature, we can ascertain several principles outlining 
priority setting decisions—health maximization, fair distribution, and equity. This 
study aims to identify the principles the public considers important, and the trade-offs 
between different values in resource allocation practices. METHODS: Two Focus 
groups were created and discussed a variety of issues on resource allocation in health 
care. Participants in the groups were introduced to the objective of the project and 
problems at hand. To facilitate the group discussion, a simple ranking task and a series 
of pair-wise choice practices were implemented. In the choice scenario, the severity of 
diseases was represented as both the quality of life and life-years remained. All par-
ticipants were expected to choose one scenario, and explain the underlying reason for 
their choice. Group discussions were recorded and later analyzed by researchers. 
RESULTS: Severity of disease was the most important criteria of priority setting for 
participants. The majority supports the idea that the most disadvantaged should have 
the highest priority, even though their health gain is less than others. Rare diseases 
were given high priority because of their severity, not their rareness. Through the focus 
group interview, we could ﬁ nd a strong public support for the equal opportunity 
principle. Next to severity of disease, socio-economic status was found to be an 
important consideration in resource allocation decision. CONCLUSIONS: The ﬁ nd-
ings from the group discussions indicate that the severity of disease and the socio-
economic status of the patient is the most important priority setting criteria in the 
national health insurance setting. To further these results, a discrete choice experiment 
with ordinary people will be conducted and discussed. 
